zur Übersicht: Risiken melden Ne­ben­wir­kungs­mel­dung rein Zu­sam­men­hang mit CO­VID-19 Eu­ro­päi­sche Da­ten­bank nach Ne­ben­wir­kun­gen Ri­si­ko­rein­for­mittelalter­tio­nen Though formerly printed there has been a transition to a situation where pharmaceutical information is available as printed volumes and on t